
Hydroxyfasudil
CAS No. 105628-72-6
Hydroxyfasudil( HA-1100 | Hydroxy-Fasudil )
Catalog No. M23260 CAS No. 105628-72-6
Hydroxyfasudil is a ROCK inhibitor(IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 50 | In Stock |
![]() ![]() |
5MG | 73 | In Stock |
![]() ![]() |
10MG | 88 | In Stock |
![]() ![]() |
25MG | 203 | In Stock |
![]() ![]() |
50MG | 371 | In Stock |
![]() ![]() |
100MG | 552 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameHydroxyfasudil
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxyfasudil is a ROCK inhibitor(IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively).
-
DescriptionHydroxyfasudil is a ROCK inhibitor(IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively).
-
In VitroHydroxyfasudil is a ROCK inhibitor, with IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively. Hydroxyfasudil also less potently inhibits PKA, with an IC50 of 37 μM, 50-fold higher than those of the ROCKs. Hydroxyfasudil increases eNOS mRNA levels, with an EC50 value of 0.8 ± 0.3 μM. Hydroxyfasudil (0-100 μM) concentration-dependently increases eNOS activity and stimulates NO production in human aortic endothelial cells (HAEC). Hydroxyfasudil (10 μM) increases the half-life of eNOS mRNA from 13 to 16 hours, but does not affect eNOS promoter activity at concentrations from 0.1 to 100 μM.
-
In VivoHydroxyfasudil (10 mg/kg, i.p.) significantly increases both the average and maximal voided volumes in SD rats. Hydroxyfasudil also significantly decreases the maximal detrusor pressure. Hydroxyfasudil (3 mg/kg, i.p) inhibits hypercontractility induced by norepinephrine in spontaneously hypertensive rats (SHRs). Furthermore, Hydroxyfasudil (3, 10 mg/kg, i.p) significantly ameliorates decreased penile cGMP contents in rats.
-
SynonymsHA-1100 | Hydroxy-Fasudil
-
PathwayApoptosis
-
TargetPKA
-
RecptorPKA|ROCK|ROCK1|ROCK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number105628-72-6
-
Formula Weight307.37
-
Molecular FormulaC14H17N3O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:31 mg/mL (100.86 mM)
-
SMILESO=C1NC=CC2=C1C=CC=C2S(=O)(N3CCNCCC3)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ray P, Wright J, Adam J, Boucharens S, Black D, Brown AR, Epemolu O, Fletcher D, Huggett M, Jones P, Laats S, Lyons A, de Man J, Morphy R, Sherborne B, Sherry L, Straten Nv, Westwood P, York M. Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. Bioorg Med Chem Lett. 2011 Feb 15;21(4):1084-8. doi: 10.1016/j.bmcl.2010.12.104. Epub 2010 Dec 28. PubMed PMID: 21251828.
molnova catalog



related products
-
H 89 2HCl
H 89 2HCl is a potent PKA inhibitor with Ki of 48 nM, 10-fold selective for PKA than PKG.
-
8-Bromo-cGMP sodium
8-Bromo-cGMP sodium is a PKG activator, a membrane-permeable analog of cGMP.
-
Piceatannol
Anti-inflammatory, immunomodulatory and antiproliferative agent.